Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute (Q73901942)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9379691%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9379691%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

J P Chute

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9379691%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D J Venzon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9379691%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

L Hankins

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9379691%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Okunieff

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9379691%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J N Frame

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9379691%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D C Ihde

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9379691%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

B E Johnson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9379691%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 October 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9379691%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9379691%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9379691%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9379691%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

901-912

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9379691%20AND%20SRC:MED&resulttype=core&format=json

Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Alkylating agents in bronchogenic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Lung cancer: clinical trial of radiotherapy alone vs. radiotherapy plus cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Clinical research on the treatment of locally advanced lung cancer.Final report of VALG protocol 13 limited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Radiotherapy alone or with chemotherapy in the treatment of small-cell carcinoma of the lung. Medical Research Council Lung Cancer Working Party

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Chemotherapy of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Extensive-disease small-cell lung cancer: the thrill of victory; the agony of defeat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Intensive weekly chemotherapy for the treatment of extensive-stage small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer. A prospective, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Non-small-cell lung cancer. Major cause of late mortality in patients with small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Treatment of testicular cancer: a new and improved model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Histopathologic classification of small cell lung cancer. Changing concepts and terminology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Small cell lung cancer: Analysis of treatment factors contributing to prolonged survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Female patients with small cell lung cancer live longer than male patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

A preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Thoracic radiotherapy variables: influence on local control in small cell lung cancer limited disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2963359-4

10.1016/S0025-6196(11)63359-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9379691%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference